InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+11.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by KANOVSKY STEPHEN M, Director. Officer active across 1 company, notably Neogenomics INC. In total, 5 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €28k. Activity tracked since 2 June 2021. The latest transaction was filed on 7 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
4,000 shares@ US$7.7811100.0% of flowCommon StockSEC:0001077183-25-000098:0
Ideal exit: 1 Feb 2026 (T+270)
11,336 shares0Common StockSEC:0001077183-24-000129:0
15,556 shares0Common StockSEC:0001077183-22-000112:0
3,081 shares0Common StockSEC:0001077183-21-000156:0
3,081 shares0Common StockSEC:0001077183-21-000156
5 of 5 declarations
About KANOVSKY STEPHEN M
Stephen M. Kanovsky is a Director at Neogenomics Inc. In this role, he contributes to corporate governance and the company's strategy. His experience in the biotechnology sector allows him to provide valuable insights to strategic discussions within the board.
